Skip to main content

Table 2 Comparison between the 2 studied groups as regards baseline sCD163 and AFP

From: Diagnostic and prognostic value of serum soluble CD163 in cirrhotic patients with hepatitis C virus-related hepatocellular carcinoma before and after locoregional therapy

Parameter

sCD163 (mg/L)

p

AFP (ng/ml)

p

Mean±SD

Range

Median

IQR

HCC group (n=40)

6.6±1.6

3.7–8.8

0.079

305

145.8–550.5

< 0.001

LC group (n=20)

6.1±1

4.9–8.3

25

12.8–110.5

  1. IQR interquartile range